[学会发表]

"A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) exhibits the optimal efficacy and superior safety profile through tumor-directed 4-1BB agonism"
发表海报 (2022 AACR)

发表海报

[学会发表]

"A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) exerts significant anti-tumor effects through tumor-directed T cell activation"
发表海报 (2021 ESMO)

发表海报

[学会发表]

"A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) shows potent anti-tumor effect through tumor-directed T cell activation"
发表海报 (2020 AACR)

发表海报